Výsledky vyhledávání - "Sandra Srbljin"

Akademický článek

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

Autor: Wietske I. Luining, Marinus J. Hagens, Dennie Meijer, Joanneke B. Ringia, Tessa de Weijer, Huseyyin O. Bektas, Rosemarijn H. Ettema, Remco J.J. Knol, Ton A. Roeleveld, Sandra Srbljin, Saskia Weltings, Jose C.C. Koppes, Reindert J.A. van Moorselaar, Pim J. van Leeuwen, Daniela E. Oprea-Lager, André N. Vis

Publikováno v: European Urology Open Science, Vol 59, Iss , Pp 55-62 (2024)

Background and objectives: The association between prostate-specific antigen (PSA) level and probability of metastatic disease on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has not yet been est

Externí odkaz: https://doaj.org/article/4a37807b64e04c43b56b5a48404fb060

Zobrazit plný text záznamu

Akademický článek

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.

Autor: Dennie Meijer, Bernard H E Jansen, Maurits Wondergem, Yves J L Bodar, Sandra Srbljin, Annelies E Vellekoop, Bram Keizer, Friso M van der Zant, Otto S Hoekstra, Jakko A Nieuwenhuijzen, Max Dahele, André N Vis, Daniela E Oprea-Lager

Publikováno v: PLoS ONE, Vol 15, Iss 10, p e0239414 (2020)

PurposeRadiolabeled Prostate-Specific Membrane Antigen (PSMA) PET/CT is the current standard-of-care for lesion detection in patients with biochemically recurrent (BCR) prostate cancer (PCa). However, rigorous verification of detected lesions is not

Externí odkaz: https://doaj.org/article/fed5bbe965cb4e7987b70f63a41adebb

Zobrazit plný text záznamu

Akademický článek

18F-DCFPyL PET/CT in primary staging of prostate cancer

Autor: Maurits Wondergem, Friso M van der Zant, Ton A Roeleveld, Sandra Srbljin, Marina S Kartachova, Annemarie van Dongen, Vera Franken, Remco J J Knol

Publikováno v: European Journal of Hybrid Imaging, Vol 2, Iss 1, Pp 1-14 (2018)

Abstract Background Correct primary staging is mandatory for therapy selection and to determine prognosis in prostate cancer patients. Commonly used diagnostic procedures including Computed Tomography (CT), Magnetic Resonance Imaging, Choline Positro

Externí odkaz: https://doaj.org/article/04adb069d5064b6c84375760e96d2b40

Zobrazit plný text záznamu

Plný text ve formátu HTML

Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer

Autor: B.H.E. Jansen, Maurits Wondergem, Reindert J.A. van Moorselaar, John M. H. de Klerk, Ronald Boellaard, Robin W. Jansen, Daniela E. Oprea-Lager, Otto S. Hoekstra, Sandra Srbljin, André N. Vis, Birgit I. Lissenberg-Witte

Publikováno v: Jansen, B H E, Jansen, R W, Wondergem, M, Srbljin, S, de Klerk, J M H, Lissenberg-Witte, B I, Vis, A N, van Moorselaar, R J A, Boellaard, R, Hoekstra, O S & Oprea-Lager, D E 2020, ' Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18 F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer ', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 61, no. 2, pp. 210-216 . https://doi.org/10.2967/jnumed.118.222513
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 61(2), 210-216

Biochemically recurrent prostate cancer (BCR) is the main indication to perform prostate-specific membrane antigen PET/CT. However, localizing BCR with prostate-specific membrane antigen PET/CT remains challenging in patients with low prostate-specif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::136535a8b4fb7f7f90f0f65ae83d05e1
https://research.vumc.nl/en/publications/917f32da-fba5-4a5d-aa3f-948e6445b583

Zobrazit plný text záznamu

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

Autor: Friso M. van der Zant, B.H.E. Jansen, Jakko A. Nieuwenhuijzen, Daniela E. Oprea-Lager, André N. Vis, D. Meijer, Sandra Srbljin, Maurits Wondergem, Y.J.L. Bodar, Max Dahele, Annelies E. Vellekoop, Otto S. Hoekstra, Bram Keizer

Publikováno v: PLoS ONE, Vol 15, Iss 10, p e0239414 (2020)
PLoS ONE, 15(10 October):e0239414. Public Library of Science
Meijer, D, Jansen, B H E, Wondergem, M, Bodar, Y J L, Srbljin, S, Vellekoop, A E, Keizer, B, van der Zant, F M, Hoekstra, O S, Nieuwenhuijzen, J A, Dahele, M, Vis, A N & Oprea-Lager, D E 2020, ' Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer ', PLoS ONE, vol. 15, no. 10 October, e0239414 . https://doi.org/10.1371/journal.pone.0239414
PLoS ONE

PURPOSE: Radiolabeled Prostate-Specific Membrane Antigen (PSMA) PET/CT is the current standard-of-care for lesion detection in patients with biochemically recurrent (BCR) prostate cancer (PCa). However, rigorous verification of detected lesions is no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a113b4ced7f67883187fe35562c347
https://doaj.org/article/fed5bbe965cb4e7987b70f63a41adebb

Zobrazit plný text záznamu

Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for

Autor: Bernard H E, Jansen, Robin W, Jansen, Maurits, Wondergem, Sandra, Srbljin, John M H, de Klerk, Birgit I, Lissenberg-Witte, André N, Vis, Reindert J A, van Moorselaar, Ronald, Boellaard, Otto S, Hoekstra, Daniela E, Oprea-Lager

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b2a6b43e51a83b9f5e16acc286c2b52
https://pubmed.ncbi.nlm.nih.gov/31481580

Zobrazit plný text záznamu

18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mL

Autor: Remco J.J. Knol, Friso M. van der Zant, Wouter A. M. Broos, Sandra Srbljin, Maurits Wondergem

Publikováno v: Clinical nuclear medicine. 44(10)

Literature shows that prostate-specific membrane antigen (PSMA) PET/CT may detect biochemical recurrence of prostate cancer at low prostate-specific antigen (PSA) levels, including detection of oligometastatic disease and hence direct metastasis-dire

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe2a4cc7900c455dfc74cd695fbd8f0
https://pubmed.ncbi.nlm.nih.gov/31274553

Zobrazit plný text záznamu

High 18Fluor-DCFPyL Uptake in Adrenal Adenomas

Autor: Sandra Srbljin, Johannes Gerrit Karel Peper, Remco J.J. Knol, Maurits Wondergem, Friso M. van der Zant

Publikováno v: Clinical Nuclear Medicine. 42:862-864

Radioisotope-labeled prostate-specific membrane antigen (PSMA) tracers have been proven accurate for detection of prostate cancer localizations. Uptake of those tracers in other malignant and benign lesions has been reported, including faint accumula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::111746d25f131976f8d528485f3fb110
https://doi.org/10.1097/rlu.0000000000001808

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání